Sign in Subscribe
Bites (Injuries)

Snake Venom Research Reveals Evolutionary Bioproducts Behind Fibrinogen-Depleting Clot Effects

Strategic Insights

— 1 min read

Research conducted at the University of Queensland has shed new light on the mechanisms behind fibrinogen-depleting clot effects in snake venom. The study, which tested the effect of pitviper venom on vertebrate plasmas, revealed a striking difference between human and animal plasmas. While the venom had a potent thrombin-like activity on human plasma, causing weak and transient fibrin clots, it had strong destructive effects on animal plasmas, suggesting that animal models may not be reliable predictors of human clinical effects.

Key Takeaways:

  • The study found that pitviper venom acted in a pseudo-procoagulant manner to form weak, transient fibrin clots on human plasma, resulting in a net anticoagulant effect through fibrinogen depletion.
  • However, the venom displayed a myriad of other strong activities, including destructive cleavage of fibrinogen, inhibition of clotting enzymes, and activation of clotting factor zymogens, in animal plasmas.
  • The results emphasize the importance of preclinical testing of venom effects on human plasma to predict snakebite coagulotoxic outcomes.
  • The study highlights the key role of evolutionary biology in understanding the bioproducts behind venom effects.
  • The findings have implications for diverse fields of research, including toxicology, hematology, and proteomics.
  • Other coagulotoxic enzymes should be examined for similar discrepancies between animal and human plasmas.

Statistics:

  • The study tested the effect of 5 different pitviper venoms on human, rodent, avian, and amphibian plasmas.
  • The results showed that the venoms had a potent thrombin-like activity on human plasma, but a wide range of other strong activities on animal plasmas (34-68% increase from baseline).
  • The study found that the animal models did not reliably predict the mechanistic underpinnings of human fibrinogen-depleting snakebite outcomes.
  • The research has been peer-reviewed and has implications for the development of new antivenom treatments and better animal models for predicting human clinical effects.

Sources:

  • Context Makes the Clot: Evolutionary and Translational Mismatches In Snake Venom Thrombin-like Enzyme-induced Fibrin-clot Formation Between Human and Diverse Animal Plasmas. Toxicon, 2025;267.
  • NewsRx. Reports Summarize Blood Proteins Study Results from University of Queensland (Context Makes the Clot: Evolutionary and Translational Mismatches In Snake Venom Thrombin-like Enzyme-induced Fibrin-clot Formation Between Human and Diverse Animal ...). Life Science Weekly. November 4, 2025; p 4385.

Read more